📍Belgium.
https://go.nature.com/3Ffh8j8
https://go.nature.com/3Ffh8j8
@iannaconelab.bsky.social et al @embojournal.org
#Immunology
www.embopress.org/doi/full/10....
@iannaconelab.bsky.social et al @embojournal.org
#Immunology
www.embopress.org/doi/full/10....
It supports T cell renewal, reduces inflammation, and lowers senescent cell burden.
Several #longevity interventions may boost it:
💊Rapamycin
🧪SGLT2 inhibitors
💊Low-dose lithium
pubmed.ncbi.nlm.nih.gov/40264357/
It supports T cell renewal, reduces inflammation, and lowers senescent cell burden.
Several #longevity interventions may boost it:
💊Rapamycin
🧪SGLT2 inhibitors
💊Low-dose lithium
pubmed.ncbi.nlm.nih.gov/40264357/
Shi &al 2018 🧪⑂
doi.org/10.1016/j.im...
Shi &al 2018 🧪⑂
doi.org/10.1016/j.im...
Sequencing data: www.ncbi.nlm.nih.gov/bioproject/P...
Sequencing data: www.ncbi.nlm.nih.gov/bioproject/P...
https://go.nature.com/4i73pIo
https://go.nature.com/4i73pIo
@jci-insight.bsky.social
insight.jci.org/articles/vie...
@jci-insight.bsky.social
insight.jci.org/articles/vie...
"iCLAP: A high-plex immunostaining with high sensitivity for co-detection of low-abundance antigens".
In this paper, we introduce ICLAP to detect and spatially map low-abundance proteins, such as senescence markers, in FFPE tissue sections.
"iCLAP: A high-plex immunostaining with high sensitivity for co-detection of low-abundance antigens".
In this paper, we introduce ICLAP to detect and spatially map low-abundance proteins, such as senescence markers, in FFPE tissue sections.
academic.oup.com/jimmunol/adv...
academic.oup.com/jimmunol/adv...
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
#Immunology #Immunotherapy
#Immunology #Immunotherapy
Protagonist Therapeutics and its partner J&J have reported four phase III wins for icotrokinra in psoriasis and expect to submit the macrocyclic peptide to the FDA later this year
Protagonist Therapeutics and its partner J&J have reported four phase III wins for icotrokinra in psoriasis and expect to submit the macrocyclic peptide to the FDA later this year
rupress.org/jem/article/...
@mreeves34.bsky.social
rupress.org/jem/article/...
@mreeves34.bsky.social
This new review explores their role and the latest therapeutic advances. 🔬
Read more in Clinical and Experimental Immunology: bit.ly/3F1Dcd5